First AD

Second AD

CURE Expert Connections

Role of Tivozanib in Renal Cell Carcinoma (RCC)

CURE Expert Connections® is a video series designed to help patients and their loved ones along their cancer care journey by offering information and expert advice from leaders in oncology care. Expert medical professionals share their knowledge and insights on an array of topics to allow for a better understanding of what to expect following a cancer diagnosis. Expert Connections hopes to bridge the gap between patients and oncology professionals to ensure no question is left unanswered.

CURE Expert Connections®

Dr Thomas Hutson reviews the TIVO-3 trial, including the most recent data that was presented at ASCO GU.

Clinical Implications of the TIVO-3 Trial

Treatment Options for Patients with Renal Cell Carcinoma (RCC)

Tivozanib: Adverse Event Profile and How Toxicities are Managed

Experience with Tivozanib in the 3rd Line Setting for Patients with RCC

Future Perspectives in Renal Cell Carcinoma (RCC)

Clinical Implications of the TIVO-3 Trial

Latest News